Table 3.

Risk association of clinical parameters at diagnosis with the disease progression in CML patients.

Clinical characteristic		OR (95% CI)	P-value	Adjusted OR (95% CI)	P-value
Age		0.16 (0.987–1.083)	0.16
Gender	Male	1 (reference)		1 (reference)
	Female	2.79 (0.77–10.04)	0.12	3.79 (0.74–19.53)	0.13*
Spleen size	<12 cm	1 (reference)		1 (reference)
	12–20 cm	0.28 (0.04–1.89)	0.19	0.22 (0.02–2.07)	0.054*
	>20 cm	0.16 (0.02–1.001)	0.05	0.11 (0.12–1.04)	0.054*
Platelet count	150–450 × 103/µL	1 (reference)		1 (reference)
	<150 × 103/µL	7.20 (0.62–83.34)	0.11	11.26 (0.49–259.23)	0.13*
	>450 × 103/µL	1.98 (0.49–7.94)	0.34	2.65 (0.56–12.65)	0.22*

*Statistically not significant (P > 0.05).